Búsqueda en vivo
TopFind está obteniendo las coincidencias más recientes para tu búsqueda.
Revisamos 5 resultados en vivo para soliris y los redujimos a 3 opciones que parecen valer más la pena comparar primero.
Los temas más fuertes en esta lista son Biologics y Rare Disease Treatment.
Fuente: Alexion Pharmaceuticals
Descripción
Soliris is a prescription monoclonal antibody used to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It is a biologic medicine administered via intravenous infusion to help prevent the destruction of red blood cells and other complications of the complement system.
Ideal para
Rare disease management, Patients with PNH or aHUS, Neuromyelitis optica spectrum disorder y Specialized biologic therapy
Valoración
Fuente: AstraZeneca Malaysia
Descripción
Soliris (Eculizumab) is a specialized monoclonal antibody and complement inhibitor provided as a 10mg/ml concentrate for infusion to treat rare immune-mediated diseases.
Ideal para
Complement inhibition, Rare immune diseases y Infusion therapy
Valoración
Fuente: AstraZeneca Malaysia
Descripción
Locally registered and approved formulation of Soliris available in Malaysia. This concentrate is intended for intravenous infusion in clinical settings for the treatment of rare conditions such as aHUS and PNH. It is regulated as a scheduled poison by the Malaysian National Pharmaceutical Regulatory Agency (NPRA).
Ideal para
Malaysian residents, Hospital Based infusion, NPRA Approved prescriptions y Local rare disease support
Valoración
| Comparar | Soliris (eculizumab) | Soliris | Soliris 10mg/ml Concentrate for Solution for Infusion |
|---|---|---|---|
| Fuente | Alexion Pharmaceuticals | AstraZeneca Malaysia | AstraZeneca Malaysia |
| Descripción | Soliris is a prescription monoclonal antibody used to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It is a biologic medicine administered via intravenous infusion to help prevent the destruction of red blood cells and other complications of the complement system. | Soliris (Eculizumab) is a specialized monoclonal antibody and complement inhibitor provided as a 10mg/ml concentrate for infusion to treat rare immune-mediated diseases. | Locally registered and approved formulation of Soliris available in Malaysia. This concentrate is intended for intravenous infusion in clinical settings for the treatment of rare conditions such as aHUS and PNH. It is regulated as a scheduled poison by the Malaysian National Pharmaceutical Regulatory Agency (NPRA). |
| Ideal para | Rare disease management, Patients with PNH or aHUS, Neuromyelitis optica spectrum disorder y Specialized biologic therapy | Complement inhibition, Rare immune diseases y Infusion therapy | Malaysian residents, Hospital Based infusion, NPRA Approved prescriptions y Local rare disease support |
| Acción | |||
| Valoración |
Si quieres empezar con la opción más equilibrada, te recomiendo:
"Soliris (eculizumab) de Alexion Pharmaceuticals."
Lo elegí porque As the original manufacturer, Alexion provides the most comprehensive safety protocols and patient support through programs like OneSource.